GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » Liabilities-to-Assets

Tauns Laboratories (TSE:197A) Liabilities-to-Assets : 0.55 (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Tauns Laboratories's Total Liabilities for the quarter that ended in Dec. 2024 was 円19,721 Mil. Tauns Laboratories's Total Assets for the quarter that ended in Dec. 2024 was 円36,013 Mil. Therefore, Tauns Laboratories's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2024 was 0.55.


Tauns Laboratories Liabilities-to-Assets Historical Data

The historical data trend for Tauns Laboratories's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories Liabilities-to-Assets Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24
Liabilities-to-Assets
0.64 0.54 0.53

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24
Liabilities-to-Assets 0.64 0.54 0.55 0.53 0.55

Competitive Comparison of Tauns Laboratories's Liabilities-to-Assets

For the Medical Instruments & Supplies subindustry, Tauns Laboratories's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tauns Laboratories's Liabilities-to-Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tauns Laboratories's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Tauns Laboratories's Liabilities-to-Assets falls into.


;
;

Tauns Laboratories Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Tauns Laboratories's Liabilities-to-Assets Ratio for the fiscal year that ended in Jun. 2024 is calculated as:

Liabilities-to-Assets (A: Jun. 2024 )=Total Liabilities/Total Assets
=15594.567/29261.325
=0.53

Tauns Laboratories's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2024 is calculated as

Liabilities-to-Assets (Q: Dec. 2024 )=Total Liabilities/Total Assets
=19721.398/36012.538
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tauns Laboratories  (TSE:197A) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Tauns Laboratories Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Tauns Laboratories's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Tauns Laboratories Business Description

Traded in Other Exchanges
N/A
Address
761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines